Benchmark: Reiterates Medicine Man Technologies (SHWZ.US) rating, adjusted from buy to buy rating, target price $2.50.
Benchmark: Reiterates Medicine Man Technologies (SHWZ.US) rating, adjusted from buy to buy rating, target price $2.50.
Benchmark Reiterates Buy on Medicine Man Technologies, Maintains $2.5 Price Target
Benchmark analyst Mike Hickey reiterates Medicine Man Technologies with a Buy and maintains $2.5 price target.
Medicine Man Technologies Inc (SHWZ) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q1 2024 Earnings Conference
The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q1 2024 Earnings Call Transcript:Financial Performance:Medicine Man Technologies reported Q1 2024 revenue of $41.6 million, a 4
Schwazze's Q1 2024 Financial Results: Takes A Hit In Colorado, Overall Cannabis Sales Up By 9%
Medicine Man Technologies, Inc., operating as Schwazze (OTC:SHWZ), announced its financial results for the first quarter ended March 31, 2024. Schwazze's interim CEO, Forrest Hoffmaster, commented on
Medicine Man Technologies Q1 2024 GAAP EPS $(0.24) Misses $(0.16) Estimate, Sales $41.601M Beat $39.834M Estimate
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.16) by 50 percent. This is a 300 percent decrease over losses of
Press Release: Schwazze Announces First Quarter 2024 Financial Results
Schwazze Announces First Quarter 2024 Financial Results Canada NewsWire DENVER, May 15, 2024 Schwazze Management to Host Conference Call Today at 5:00 p.m. Eastern Time DENVER, May 15, 2024 /CNW/
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 P.m. ET
DENVER, April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, Ma
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal T
MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Officer Buys US$105 in Common Stock
$MEDICINE MAN TECHNOLOGIES INC(SHWZ.US)$ Officer Pabon Daniel purchased 150 shares of common stock on Apr 11, 2024 at an average price of $0.7 for a total value of $105.Source: Announcement What is st
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector. Despite an overall increa
Medicine Man Technologies GAAP EPS of -$0.43, Revenue of $43.3M Misses by $2.17M
Schwazze Reports Slight Revenue Drop In Q4 2023 Amid 'Fierce' Competition In Cannabis Retail Sector
Medicine Man Technologies, Inc. (OTC:SHWZ), operating as Schwazze, announced its financial and operational results on Thursday for the fourth quarter and full year ended Dec. 31, 2023."This past year,
Medicine Man Technologies Is Maintained at Buy by Benchmark
Medicine Man Technologies Is Maintained at Buy by Benchmark
Benchmark Maintains Buy on Medicine Man Technologies, Lowers Price Target to $2.5
Benchmark analyst Mike Hickey maintains Medicine Man Technologies with a Buy and lowers the price target from $3 to $2.5.
Medicine Man Technologies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/28/2024 237.38% Benchmark $3 → $2.5 Maintains Buy 03/30/2023 304.86% Benchmark → $3 Reiterates → Buy 12
Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q4 2023 Earnings Conference
The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript:Financial Performance:Medicine Man Technologies (Schwazze) reported Q4 revenue of $43.3 millio
Medicine Man Technologies Q4 EPS $(0.38) Misses $(0.13) Estimate, Sales $43.33M Miss $45.47M Estimate
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.13) by 192.31 percent. This is a 22.58 percent decrease over loss
Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M
04:14 PM EDT, 03/27/2024 (MT Newswires) -- Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M
Medicine Man Technologies 4Q Rev $43.3M >SHWZ
Medicine Man Technologies 4Q Rev $43.3M >SHWZ
No Data